GS7A Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - GlaxoSmithKline PLC

Watchlist Manager

Watchlist

Price: 31.2 EUR -1.89% Market Closed

Market Cap: €79.3B

G	GlaxoSmithKline PLC F:GS7A	UK
P	PT Trimegah Bangun Persada Tbk IDX:NCKL	ID
	Orthex Oyj F:4QU	FI
A	Apollo Medical Holdings Inc F:3AM	US
A	Ameresco Inc F:4AM	US
D	Dongfang Electric Corp Ltd OTC:DNGFF	CN
K	KB Home BMV:KBH	US
	EDA Group Holdings Ltd F:7OZ	CN
J	JinkoSolar Holding Co Ltd F:ZJS1	CN
A	Ad Pepper Media International NV XBER:APM	DE
	Kenvue Inc F:J4D	US
H	Hackett Group Inc F:AWT	US

Profitability Summary

GlaxoSmithKline PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

73%

Strong 3Y Average Gross Margin

72%

Gross Margin is Increasing

72% > 73%

Healthy Operating Margin

27%

Sustainable 3Y Average Operating Margin

26%

Operating Margin is Increasing

26% > 27%

Healthy Net Margin

18%

Sustainable 3Y Average Net Margin

17%

Declining Net Margin

53% > 18%

Exceptional Free Cash Flow Margin

15%

Strong 3Y Average Free Cash Flow Margin

14%

Free Cash Flow Margin is Increasing

8% > 15%

Exceptional ROE

36%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

18%

ROIC is Increasing

13% > 18%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.